Skip to main content
Premium Trial:

Request an Annual Quote

NEWS BRIEF: Exelixis, Merck to Build Small-Molecule Libraries

NEW YORK, May 1 - Exelixis and pharma giant Merck will design and develop small-molecule compound libraries for high-throughput drug screening, Exelixis said today.


Both firms will own the libraries, which will be used for internal lead-discovery programs as well as in collaborative research ventures, the partners said.

Exelixis will bring to the table small molecules, analytics, informatics, and formatting.


Click here for more information.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.